Corning, Biological Industries Announce Agreement for Co-branded NutriStem® hPSC XF Medium

We use cookies to ensure the best experience on our website.
View Cookie Policy
Accept Cookie Policy
Change My Settings
Required for the site to function.
Augment your site experience.
Lets Corning work with partners to enable social features and marketing messages.
Corning to offer co-branded NutriStem® medium for pluripotent stem cell culture

Corning and Biological Industries Announce Agreement for Co-branded NutriStem® hPSC XF Medium

Agreement for Co-branded NutriStem® hPSC XF Medium

News Releases
Life Sciences
Corning, Biological Industries Announce Agreement for Co-branded NutriStem® hPSC XF Medium
Corning, Biological Industries Announce Agreement for Co-branded NutriStem® hPSC XF Medium
CORNING, N.Y. | Corning Incorporated | June 22, 2016

Corning Incorporated (NYSE: GLW) subsidiary, Mediatech, Inc., and Biological Industries, Ltd. (BI) today announced an agreement to enable cell therapy research and manufacturing organizations to purchase the innovative, xeno-free human pluripotent stem-cell (hPSC) medium in conjunction with Corning’s other leading stem-cell culture products.

“This product augments our growing portfolio of media and reagents, and our technical team has shown excellent results using NutriStem hPSC Medium in combination with our advanced cell culture surfaces and vessels,” said Keith Olson director, business operations, Corning Life Sciences. “Corning continues to innovate across our portfolio, both through our internal development as well as through external relationships with exceptional technology developers.”

The jointly branded NutriStem® hPSC Medium will continue to be manufactured by BI, but supported by Corning’s global commercial team. This medium was developed by BI in collaboration with the Technion – Israel Institute of Technology. Since its release in 2009, the media have been increasingly adopted by leading academic and commercial labs for use in hPSC culture.

“Corning is a market leader in cell culture and brings broad access to life science customers globally,” said Alon Ariel, chief executive officer, BI. “It is critical for our products to have high availability for researchers’ workflows, now that stem cell research and development are accelerating into clinical trials and therapeutic use. Corning has both the complementary products and the commercial breadth to facilitate this.”

Corning Life Sciences continues to bring new and innovative laboratory technologies to researchers worldwide and helps customers succeed by providing novel, high-quality products and services in cell culture, bioprocessing, drug discovery and development, genomics, and microbiology.

To learn more about Corning Life Sciences products, please contact a customer service representative at 1-800-492-1110, toll free in the United States; (+1) 1-978-442-2200 internationally; or visit

Forward-Looking and Cautionary Statements
This press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.

Digital Media Disclosure
In accordance with guidance provided by the SEC regarding the use of company websites and social media channels to disclose material information, Corning Incorporated (“Corning”) wishes to notify investors, media, and other interested parties that it intends to use its website ( to publish important information about the company, including information that may be deemed material to investors. The list of websites and social media channels that the company uses may be updated on Corning’s media and website from time to time. Corning encourages investors, media, and other interested parties to review the information Corning may publish through its website and social media channels as described above, in addition to the company’s SEC filings, press releases, conference calls, and webcasts.

About Biological Industries
Biological Industries ( is one of the world’s leading and trusted suppliers to the life sciences industry, with over 30 years’ experience in cell culture media development and manufacturing. BI’s products range from classical cell culture media to supplements and reagents for stem cell research and potential cell therapy applications to serum-free media and many other products for animal cell culture and molecular biology. BI is committed to a Culture of Excellence through advanced manufacturing and quality-control systems, regulatory expertise, in-depth market knowledge, and extensive technical customer-support, training and R&D capabilities. 

About Corning Incorporated
Corning ( is one of the world’s leading innovators in materials science. For more than 160 years, Corning has applied its unparalleled expertise in specialty glass, ceramics, and optical physics to develop products that have created new industries and transformed people’s lives. Corning succeeds through sustained investment in R&D, a unique combination of material and process innovation, and close collaboration with customers to solve tough technology challenges. Corning’s businesses and markets are constantly evolving. Today, Corning’s products enable diverse industries such as consumer electronics, telecommunications, transportation, and life sciences. They include damage-resistant cover glass for smartphones and tablets; precision glass for advanced displays; optical fiber, wireless technologies, and connectivity solutions for high-speed communications networks; trusted products that accelerate drug discovery and manufacturing; and emissions-control products for cars, trucks, and off-road vehicles.